On June 5, 2023, Conformal Medical Inc., developer of a left atrial appendage occlusion system, announced a successful Series D funding round, raising a total of $35 million. The round was led by ...

On the first day of the 2016 CardioStim sessions, I am happy to report a "positive" study on percutaneous left atrial appendage closure [1]. Notice I did not write Watchman. In Europe, the majority of ...

The Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Society (HRS) have released an updated expert consensus statement on transcatheter left atrial appendage closure ...

For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

Catheter Precision, Inc., a US medical device company specializing in cardiac electrophysiology, will attend the 13th International Symposium on Left Atrial Appendage (ISLAA) in Austin, Texas on ...

The Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Society (HRS) have published the first rigorous, evidence-based, multisociety recommendations to guide the use of ...

PHOENIX -- A novel transcatheter device that twists the left atrial appendage (LAA) closed from the inside appeared safe in first-in-human results. Among 15 atrial fibrillation patients who received ...

Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation, left atrial appendage closure was superior to anticoagulation for bleeding ...

SAN FRANCISCO — Thirteen months after percutaneous left atrial appendage closure (LAAC), outcomes did not differ whether closure was performed using the Amulet (Abbott Cardiovascular) or the Watchman ...

In the PROTECT AF trial, patients randomized to left atrial appendage closure initially continued taking warfarin and aspirin to promote device endothelialization. At 45 days after the procedure, 86.8 ...

Where's the Beef? Managing Severe Aortic Stenosis in a Patient with Severe Alpha-Galatosidase Allergy Receive the the latest news, research, and presentations from major meetings right to your inbox.